Counting chickens before the eggs hatch: Associating new product development portfolios with shareholder expectations in the pharmaceutical sector
- 31 December 2008
- journal article
- Published by Elsevier in International Journal of Research in Marketing
- Vol. 25 (4) , 261-272
- https://doi.org/10.1016/j.ijresmar.2008.07.001
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Productivity in pharmaceutical–biotechnology R&D: the role of experience and alliancesJournal of Health Economics, 2005
- Diffusion of new pharmaceutical drugs in developing and developed nationsInternational Journal of Research in Marketing, 2004
- Country and consumer segmentation: multi-level latent class analysis of financial product ownershipInternational Journal of Research in Marketing, 2004
- Understanding and managing international growth of new productsInternational Journal of Research in Marketing, 2004
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Product diversification in international joint ventures: performance implications in an emerging marketStrategic Management Journal, 2001
- Unobserved Heterogeneity as an Alternative Explanation for “Reversal” Effects in Behavioral ResearchJournal of Consumer Research, 2000
- Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in BiotechnologyAdministrative Science Quarterly, 1996
- Research and Development Costs for New Drugs by Therapeutic CategoryPharmacoEconomics, 1995
- A maximum likelihood methodology for clusterwise linear regressionJournal of Classification, 1988